(JHG) Janus Henderson - Ratings and Ratios
Equity Funds, Fixed-Income Funds, Balanced Funds, Private Equity, Real-Estate
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.78% |
| Yield on Cost 5y | 5.76% |
| Yield CAGR 5y | 1.47% |
| Payout Consistency | 97.8% |
| Payout Ratio | 41.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.9% |
| Value at Risk 5%th | 33.2% |
| Relative Tail Risk | -7.59% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | -8.45 |
| CAGR/Max DD | 0.79 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.448 |
| Beta | 1.435 |
| Beta Downside | 1.649 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.29% |
| Mean DD | 6.93% |
| Median DD | 4.82% |
Description: JHG Janus Henderson January 08, 2026
Janus Henderson Group plc (NYSE:JHG) is a UK-based asset-management holding company that serves institutional, retail, and high-net-worth clients through a suite of equity, fixed-income, and balanced mutual funds, as well as private-equity and real-estate investments. Its product focus spans growth-capital, middle-market buyouts, and a broad set of sector exposures-including commercial services, logistics, consumer durables, hospitality, health care, financial services, REITs, and alternative-energy assets-across both public and private markets, with a particular emphasis on companies in China and India.
Key metrics as of the latest FY2023 filing show approximately $400 billion in assets under management (AUM), a net inflow of $9 billion for the year, and a dividend yield near 2.5 %. The firm’s revenue mix is roughly 55 % fee-based (management fees) and 45 % performance-based, reflecting a shift toward recurring fee structures amid industry pressure from passive alternatives. Macro drivers that materially affect Janus Henderson include global interest-rate trends (which influence fixed-income demand), the ongoing reallocation to ESG-aligned funds, and the growth of emerging-market capital flows, especially in India’s expanding middle-class consumer sector.
For a deeper, data-driven view of JHG’s valuation and risk profile, you may find it useful to explore the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (534.5m TTM) > 0 and > 6% of Revenue (6% = 159.8m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 0.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 88.95% (prev 90.81%; Δ -1.85pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 644.1m > Net Income 534.5m (YES >=105%, WARN >=100%) |
| Net Debt (-601.5m) to EBITDA (776.2m) ratio: -0.77 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (154.8m) change vs 12m ago 0.06% (target <= -2.0% for YES) |
| Gross Margin 69.16% (prev 69.14%; Δ 0.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 35.80% (prev 32.12%; Δ 3.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 29.30 (EBITDA TTM 776.2m / Interest Expense TTM 25.3m) >= 6 (WARN >= 3) |
Altman Z'' 3.80
| (A) 0.31 = (Total Current Assets 3.15b - Total Current Liabilities 784.3m) / Total Assets 7.61b |
| (B) 0.16 = Retained Earnings (Balance) 1.18b / Total Assets 7.61b |
| (C) 0.10 = EBIT TTM 741.2m / Avg Total Assets 7.44b |
| (D) 0.55 = Book Value of Equity 1.07b / Total Liabilities 1.94b |
| Total Rating: 3.80 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 71.74
| 1. Piotroski 5.50pt |
| 2. FCF Yield 9.42% |
| 3. FCF Margin 23.81% |
| 4. Debt/Equity 0.08 |
| 5. Debt/Ebitda -0.77 |
| 6. ROIC - WACC (= 0.94)% |
| 7. RoE 11.35% |
| 8. Rev. Trend 40.97% |
| 9. EPS Trend 7.80% |
What is the price of JHG shares?
Over the past week, the price has changed by +0.38%, over one month by +5.38%, over three months by +11.99% and over the past year by +22.60%.
Is JHG a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the JHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.7 | 3.7% |
| Analysts Target Price | 49.7 | 3.7% |
| ValueRay Target Price | 56.8 | 18.4% |
JHG Fundamental Data Overview January 13, 2026
P/E Forward = 10.917
P/S = 2.7702
P/B = 1.4937
P/EG = 0.9836
Beta = 1.532
Revenue TTM = 2.66b USD
EBIT TTM = 741.2m USD
EBITDA TTM = 776.2m USD
Long Term Debt = 395.4m USD (from longTermDebt, last quarter)
Short Term Debt = 16.6m USD (from shortTermDebt, last fiscal year)
Debt = 395.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -601.5m USD (from netDebt column, last quarter)
Enterprise Value = 6.73b USD (7.38b + Debt 395.4m - CCE 1.04b)
Interest Coverage Ratio = 29.30 (Ebit TTM 741.2m / Interest Expense TTM 25.3m)
EV/FCF = 10.62x (Enterprise Value 6.73b / FCF TTM 634.0m)
FCF Yield = 9.42% (FCF TTM 634.0m / Enterprise Value 6.73b)
FCF Margin = 23.81% (FCF TTM 634.0m / Revenue TTM 2.66b)
Net Margin = 20.07% (Net Income TTM 534.5m / Revenue TTM 2.66b)
Gross Margin = 69.16% ((Revenue TTM 2.66b - Cost of Revenue TTM 821.4m) / Revenue TTM)
Gross Margin QoQ = 70.67% (prev 69.06%)
Tobins Q-Ratio = 0.88 (Enterprise Value 6.73b / Total Assets 7.61b)
Interest Expense / Debt = 1.59% (Interest Expense 6.30m / Debt 395.4m)
Taxrate = 19.91% (45.0m / 226.0m)
NOPAT = 593.6m (EBIT 741.2m * (1 - 19.91%))
Current Ratio = 4.02 (Total Current Assets 3.15b / Total Current Liabilities 784.3m)
Debt / Equity = 0.08 (Debt 395.4m / totalStockholderEquity, last quarter 4.78b)
Debt / EBITDA = -0.77 (Net Debt -601.5m / EBITDA 776.2m)
Debt / FCF = -0.95 (Net Debt -601.5m / FCF TTM 634.0m)
Total Stockholder Equity = 4.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.18% (Net Income 534.5m / Total Assets 7.61b)
RoE = 11.35% (Net Income TTM 534.5m / Total Stockholder Equity 4.71b)
RoCE = 14.52% (EBIT 741.2m / Capital Employed (Equity 4.71b + L.T.Debt 395.4m))
RoIC = 11.63% (NOPAT 593.6m / Invested Capital 5.10b)
WACC = 10.70% (E(7.38b)/V(7.77b) * Re(11.20%) + D(395.4m)/V(7.77b) * Rd(1.59%) * (1-Tc(0.20)))
Discount Rate = 11.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -1.70%
[DCF Debug] Terminal Value 69.58% ; FCFF base≈620.4m ; Y1≈644.3m ; Y5≈735.7m
Fair Price DCF = 60.24 (EV 8.40b - Net Debt -601.5m = Equity 9.00b / Shares 149.4m; r=10.70% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: 7.80 | EPS CAGR: -47.59% | SUE: -4.0 | # QB: 0
Revenue Correlation: 40.97 | Revenue CAGR: 0.12% | SUE: 0.43 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.96 | Chg30d=+0.010 | Revisions Net=+0 | Analysts=6
EPS next Year (2026-12-31): EPS=4.38 | Chg30d=+0.053 | Revisions Net=+2 | Growth EPS=+9.6% | Growth Revenue=+8.6%
Additional Sources for JHG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle